Clinical Trial

Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC

Name: Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC — clinical trial record (NCT07596134)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HLP1-1331

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Multimodal Thermal Therapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy alone for systemically untreated unresectable hepatocellular carcinoma (HCC)

Protocol Amendment History 1 change

critical Primary endpoint(s) modified 2026-05-23

Trial Details

NCT Number	NCT07596134
Lead Sponsor	Zhejiang University
Conditions	Unresectable Hepatocellular Carcinoma (HCC)
Enrollment	166 participants
Start Date	2026-05-25
Primary Completion	2028-05-25 (estimated)
Study Completion	2029-05-25 (estimated)
Updated on ClinicalTrials.gov	2026-05-22